郑州做近视眼手术需要多少费用(郑州飞秒手术多少钱) (今日更新中)

SAN DIEGO (KGTV) -- For the first time in over two decades, there will be a new San Diego County Supervisor for District 1. Nora Vargas will be the first Latina to ever serve on the Board of Supervisors. The Democrat will take over for Supervisor Greg Cox, who is termed out. She beat her Democratic opponent, state Sen. Ben Hueso, by roughly 13%. Nora Vargas, a Chula Vista resident, said her background is in health care and education. She's served on the board at Southwestern College since 2013; she's been board president since 2018. She's also an executive at Planned Parenthood. Vargas said her top priority as she heads into office is the COVID-19 pandemic. District 1 primarily serves the South Bay, which is one of the areas hardest hit by the pandemic in the entire county. "For me, it’s really important that we find a balance -- how do we make sure that our small businesses are thriving, that they stay open but at the same time that our communities are healthy and safe? That has to be a priority," explained Vargas. Vargas was born in Tijuana and raised in Chula Vista where she became a U.S. citizen. As the first Latina to serve on the board, she hopes she won't be the last. "I see that as a big responsibility but also as a great opportunity to have dialogue about the issues that really matter for our communities," said Vargas. Other priorities for Vargas include housing security, a climate action plan and economic recovery.Vargas will be sworn in on Jan. 4. 1490

SAN DIEGO (KGTV) — Governor Gavin Newsom’s vaccine safety task force will have to work quickly once the FDA announces a decision on Pfizer’s COVID-19 vaccine candidate.The 11-member panel, officially called the Scientific Safety Review Workgroup, has been tasked with reviewing the safety and efficacy of vaccine trials and rendering a recommendation on their use in California.The workgroup has a difficult mission: review the data thoroughly enough to offer a recommendation independent from the FDA, but do it fast enough to avoid delaying distribution of the vaccine.Pfizer’s emergency use authorization application spans thousands of pages.The workgroup has already reviewed Pfizer’s early-stage clinical trial data from phases 1 and 2 and found no cause for concern, Governor Gavin Newsom said. They’re still waiting to get their hands on the all-important Phase 3 data, which included thousands of participants.Panel member Dr. Rodney Hood, the president of the Multicultural Health Foundation, acknowledged the task force will have to complete its review of the Phase 3 data “very, very quickly.” Dr. Hood is one of two members from the San Diego region, along with Dr. Mark Sawyer of Rady Children’s Hospital.“We certainly don't want to introduce any unnecessary delay in the vaccine being available to Californians,” Dr. Sawyer said.The FDA has scheduled a meeting of its vaccine advisory committee, known by its acronym VRBPAC (pronounced verb-pack), on Dec. 10. The agency said it will make Pfizer’s Phase 3 data available at least two days before that meeting.At the end of that meeting, a group of about 20 experts on the advisory committee will vote on whether to recommend emergency authorization of the vaccine. The FDA is expected to issue a decision shortly after, although the agency does not have to abide by the advisory committee’s recommendation.“The California committee is on notice to be ready for a meeting either later in the day on the 10th or on December 11,” said Dr. Sawyer.Dr. Sawyer was recently added to VRBPAC, so he will cast a vote on whether to recommend approval of the vaccine at the national level before participating in California’s process.“It is going to take a few days for the vaccine to really start flowing,” he said. “I don't think the [California] committee is going to introduce extra delay.”The California committee has promised to issue its decision within 24 hours of the FDA’s to avoid slowing down distribution, but that means the members may have as few as three days to review the safety and efficacy data.Federal regulators will spend about three weeks reviewing the thousands of pages of data submitted as part of Pfizer’s application. VRBPAC and the California Scientific Safety Review Workgroup will render decisions based on summaries prepared by the FDA, Dr. Sawyer said.Both doctors say they have confidence in the FDA’s process and acknowledge it would be very unlikely for the California workgroup to break with the agency’s recommendation. They said the mission of their review is to add an extra layer of verification after complaints the Trump administration was exercising political pressure on the FDA.“I think the governor foresaw that it was going to be very important that the general community accept these vaccines, assuming they're approved and are safe and effective, because otherwise we're not going to get out of this pandemic,” Dr. Sawyer said.The doctors say they want to make sure that community acceptance extends across all demographics, so they’ll be looking closely at the numbers to see if various ethnic or racial groups had different responses to the vaccine.Based on research on past vaccines, a differential response is not expected, Dr. Hood said. However, COVID-19 does strike Latinos and African-Americans more severely, making vaccine acceptance among minority communities all the more critical.“I want to look at the data, get an assessment of risk-benefit and the question I ask is, would I take it? Number one. Number two, if I would take it, would I recommend it to my family?” he said.The doctors said they will also closely examine reports of side effects.Early data suggests both Pfizer and Moderna’s candidates have somewhat harder-hitting side effects than the typical flu vaccine. Dr. Sawyer compared the side effects to the recent shingles vaccine.“Your arm hurts for a day or two. You may not feel well. You may feel a little bit under the weather for the first 24 hours. You could even have a mild fever or headache,” he said, noting those symptoms typically resolve within 24 to 48 hours based on the data available so far.“That's actually a good sign. You want that to happen,” he added.Those sorts of short-term side effects are signs the body is building a strong immune response. They’re evidence the vaccines work as well as advertised, but the doctors say they won’t know for certain until they review the final numbers. 4949

SAN DIEGO (KGTV) - Holiday fun from around the world is coming to San Diego this season, as Global Winter Wonderland pops up at SDCCU Stadium.The multicultural theme park set up at the Mission Valley stadium features a circus of lights, a carnival, holiday-themed displays of locations around the world, an international food court, holiday shopping, and Santa (along with his trusty penguin, Penny.)RELATED: Southern California theme parks celebrate the holidays with festive eventsThe festival of holiday lights and music runs at the stadium on select dates from Nov. 11, 2017, to Jan. 7, 2018: 614

SAN DIEGO (KGTV) - Driving in San Diego is starting to look like Los Angeles - or worse.For many San Diegans, the morning and afternoon commutes are more congested than the year before.Equinox Project, a research group, reported that San Diego drivers spent more than 19 hours stuck in traffic last year. The statistic is 30 minutes higher than 2016.“San Diego traffic wasn't even a thought back in the day,” said commuter Omid Sabet.San Diegans traveled 29 freeway miles per day in 2017, more than any other major county in California. By comparison, Los Angeles drivers traveled only 23 highway miles.“People want to buy houses, rent houses, but they’re getting pushed farther and farther away,” said Mikaela Bolling with Equinox Project.The number of solo drivers dropped half a percent in 2017.“It’s a small decrease but it’s good news that more people are carpooling, biking or walking to work,” Bolling said.Few San Diegans are using public transit or bike lanes but Bolling believes that could change.“There are more bike lanes being put in, so more people may be biking to work. Also, walkable neighborhoods, more people may be living closer to where they work.”  1189

SAN DIEGO (KGTV) -- For the first time in nearly 100 years, an integrated company of male and female recruits at MCRD San Diego are about to begin their journey into becoming Marines. These future Marines will be led by graduates from MCRD's first ever integrated Drill Instructor Course. Now the mission of the course is to screen, train, and further develp leadership and command presence of selected Marines, in order to successfully perform duties of a drill instructor."We are taking them from the leadership skills, that they had in the fleet, and further refining them here," says Major Lynn Stow, Director of the MCRD San Diego Drill Instructor Course. "The drill instructor's goal is to successfully transfer recruits into United States Marines."Fifty-seven Marines are scheduled to graduate from the grueling 57 day course, and for the very first time, the graduating class will include 3 females."Getting the opportunity to come here was almost like divine intervention, everything just kind of fell into place," says student Sargent Stephanie Fahl. "To come here and make it this far, I'm really proud of myself."These future drill instructors at MCRD are looking forward to changing the lives of young 17 and 18-year-old recruits. "The change I'd like to instill in the recruits is to obviously maintain that discipline that's a staple of recruit training,"says student Sargent Stephanie Jordi. "I'd also like to inspire them and teach them how to become leaders even from that lowest level." Student Sargent Ikea Kaufman feels being a drill instructor is about teaching recruits how to be men and women."There is more to life than social media and all that. There is actually responsibility."And while Drill Instructor Course is very rigorous, the payback is immense. "You have contributed to the mission of making Marines. You have been able to take these recruits from day one and transform them into Marines. They are going to look up to you as their role model." 1991

来源：资阳报